A drug-first approach

Drug discovery with a head start

Tavros employs an integrated high-throughput functional genomics discovery platform to uncover unique weaknesses in cancer cells that are exposed by drug treatment. These context-specific vulnerabilities point us to a clear clinical path for novel drug development with the knowledge of predictive biomarkers and optimal drug combinations that improve therapeutic response. We use this dynamic discovery engine to identify first-in-class drug targets with a clear path forward to the clinic to get the right drugs to the right patients, faster.